Jason E. Duex

2.7k total citations · 1 hit paper
22 papers, 1.8k citations indexed

About

Jason E. Duex is a scholar working on Molecular Biology, Cell Biology and Surgery. According to data from OpenAlex, Jason E. Duex has authored 22 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 8 papers in Cell Biology and 7 papers in Surgery. Recurrent topics in Jason E. Duex's work include Cellular transport and secretion (7 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Epigenetics and DNA Methylation (4 papers). Jason E. Duex is often cited by papers focused on Cellular transport and secretion (7 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Epigenetics and DNA Methylation (4 papers). Jason E. Duex collaborates with scholars based in United States and Ukraine. Jason E. Duex's co-authors include Lois S. Weisman, Dan Theodorescu, Jin-Fen Xiao, Neeraj Agarwal, Linda L. Tran, Alexander Sorkin, Fusheng Tang, Johnathan J. Nau, Emily J. Kauffman and Garrett M. Dancik and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Cell Biology.

In The Last Decade

Jason E. Duex

20 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Advances in bladder cancer biology and therapy

2020 456 citations Linda L. Tran, Jin-Fen Xiao et al. Nature reviews. Cancer profile →

Peers

Countries citing papers authored by Jason E. Duex

Since Specialization

Citations

This map shows the geographic impact of Jason E. Duex's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason E. Duex with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason E. Duex more than expected).

Fields of papers citing papers by Jason E. Duex

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason E. Duex. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason E. Duex. The network helps show where Jason E. Duex may publish in the future.

Co-authorship network of co-authors of Jason E. Duex

This figure shows the co-authorship network connecting the top 25 collaborators of Jason E. Duex. A scholar is included among the top collaborators of Jason E. Duex based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason E. Duex. Jason E. Duex is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genes driving three-dimensional growth of immortalized cells and cancer 2025 ·Cell Death and Disease ·(unknown), Jin-Fen Xiao, Saravana Kumar Kailasam Mani, (unknown), (unknown), Jason E. Duex, Huihui Ye, (unknown), Dan Theodorescu	0
2	CD44 in Bladder Cancer 2024 ·Cancers ·Jason E. Duex, Dan Theodorescu	6
3	Targetable Pathways in Advanced Bladder Cancer: FGFR Signaling 2021 ·Cancers ·Jin-Fen Xiao, Andrew W. Caliri, Jason E. Duex, Dan Theodorescu	32
4	Inhibition of the CCL2 receptor, CCR2, enhances tumor response to immune checkpoint therapy 2020 ·Communications Biology ·Megan M. Tu, Hany Abdel-Hafiz, Robert T. Jones, Annie Jean, (unknown), Jason E. Duex, (unknown), James C. Costello, Garrett M. Dancik, Beth A. Jirón Tamburini, Bogdan Czerniak, Jonathan Kaye, Dan Theodorescu	125
5	Advances in bladder cancer biology and therapy breakdown → 2020 ·Nature reviews. Cancer ·Linda L. Tran, Jin-Fen Xiao, Neeraj Agarwal, Jason E. Duex, Dan Theodorescu	456
6	Nuclear CD24 Drives Tumor Growth and Is Predictive of Poor Patient Prognosis 2017 ·Cancer Research ·Jason E. Duex, Charles R. Owens, (unknown), Garrett M. Dancik, Lauren A. Vanderlinden, Debashis Ghosh, (unknown), Donna E. Hansel, Dan Theodorescu	22
7	Functional Impact of Chromatin Remodeling Gene Mutations and Predictive Signature for Therapeutic Response in Bladder Cancer 2017 ·Molecular Cancer Research ·Jason E. Duex, (unknown), Garrett M. Dancik, Richard D. Paucek, Charles R. Owens, Mair E. A. Churchill, Dan Theodorescu	32
8	GON4L Drives Cancer Growth through a YY1–Androgen Receptor–CD24 Axis 2016 ·Cancer Research ·Neeraj Agarwal, Garrett M. Dancik, Andrew Goodspeed, James C. Costello, Charles R. Owens, Jason E. Duex, Dan Theodorescu	42
9	Patient Mutation Directed shRNA Screen Uncovers Novel Bladder Tumor Growth Suppressors 2015 ·Molecular Cancer Research ·Jonathan A. Hensel, Jason E. Duex, Charles R. Owens, Garrett M. Dancik, Michael G. Edwards, Henry F. Frierson, Dan Theodorescu	25
10	Role in Tumor Growth of a Glycogen Debranching Enzyme Lost in Glycogen Storage Disease 2014 ·JNCI Journal of the National Cancer Institute ·Sunny Guin, Courtney Pollard, Yuanbin Ru, Carolyn R. Lew, Jason E. Duex, Garrett M. Dancik, Charles R. Owens, Andrea E. Spencer, (unknown), (unknown), Sounak Gupta, Donna E. Hansel, Marc K. Hellerstein, Pawel Lorkiewicz, Andrew N. Lane, Teresa W.‐M. Fan, Dan Theodorescu	36
11	Usp18 Regulates Epidermal Growth Factor (EGF) Receptor Expression and Cancer Cell Survival via MicroRNA-7 2011 ·Journal of Biological Chemistry ·Jason E. Duex, Laurey Comeau, Alexander Sorkin, Benjamin Purow, Benjamin Kefas	59
12	Recruitment of Uev1B to Hrs-containing endosomes and its effect on endosomal trafficking 2010 ·Experimental Cell Research ·Jason E. Duex, (unknown), Alexander Sorkin	8
13	Quantitative Analysis of Endocytosis and Turnover of Epidermal Growth Factor (EGF) and EGF Receptor 2010 ·Current Protocols in Cell Biology ·Alexander Sorkin, Jason E. Duex	71
14	RNA Interference Screen Identifies Usp18 as a Regulator of Epidermal Growth Factor Receptor Synthesis 2009 ·Molecular Biology of the Cell ·Jason E. Duex, Alexander Sorkin	41
15	VAC14 nucleates a protein complex essential for the acute interconversion of PI3P and PI(3,5)P2 in yeast and mouse 2008 ·The EMBO Journal ·Natsuko Jin, Clement Y. Chow, Li Liu, Sergey N. Zolov, Roderick Bronson, Muriel T. Davisson, Jason L. Petersen, Yanling Zhang, Sujin Park, Jason E. Duex, Dan Goldowitz, Miriam H. Meisler, Lois S. Weisman	187
16	The Vac14p–Fig4p complex acts independently of Vac7p and couples PI3,5P2 synthesis and turnover 2006 ·The Journal of Cell Biology ·Jason E. Duex, Fusheng Tang, Lois S. Weisman	117
17	Phosphoinositide 5-Phosphatase Fig4p Is Required for both Acute Rise and Subsequent Fall in Stress-Induced Phosphatidylinositol 3,5-Bisphosphate Levels 2006 ·Eukaryotic Cell ·Jason E. Duex, Johnathan J. Nau, Emily J. Kauffman, Lois S. Weisman	122
18	Osmotic stress–induced increase of phosphatidylinositol 3,5-bisphosphate requires Vac14p, an activator of the lipid kinase Fab1p 2002 ·The Journal of Cell Biology ·(unknown), Johnathan J. Nau, Jason E. Duex, (unknown), Andrew E. Wurmser, Jonathan D. Gary, Scott D. Emr, Lois S. Weisman	215
19	Fusion of Docked Membranes Requires the Armadillo Repeat Protein Vac8p 2001 ·Journal of Biological Chemistry ·(unknown), Emily J. Kauffman, Jason E. Duex, Lois S. Weisman	73
20	Two Distinct Regions in a Yeast Myosin-V Tail Domain Are Required for the Movement of Different Cargoes 2000 ·The Journal of Cell Biology ·Natalie L. Catlett, Jason E. Duex, Fusheng Tang, Lois S. Weisman	85

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact